Cardinal Health

Last updated
Cardinal Health, Inc.
Company type Public
Industry Healthcare
Founded1971;53 years ago (1971)
Founder Robert D. Walter
Headquarters Dublin, Ohio, U.S.
Area served
Worldwide
Key people
  • Jason Hollar (CEO)
  • Deborah Weitzman (CEO, pharma segment)
  • Stephen Mason (CEO, medical segment)
ProductsMedical and pharmaceutical products and services
RevenueIncrease2.svg US$227 billion (2024)
Increase2.svgUS$1.24 billion (2024)
Increase2.svgUS$852 million (2024)
Total assets Increase2.svgUS$45.1 billion (2024)
Total equity Decrease2.svgUS$−3.2 billion (2024)
Number of employees
48,900 (2024)
Website cardinalhealth.com
Footnotes /references
Financials as of June 30,2024. [1]

Cardinal Health, Inc. is an American multinational health care services company, and the 14th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. [2] Cardinal Health provides medical products to over 75 percent of hospitals in the United States. [3]

Contents

History

Founded in 1971 as Cardinal Foods by Robert D. Walter, the company was initially a food wholesaler. [4] After acquiring the Bailey Drug Company in 1979, it began whole selling drugs. [5] The company went public on the NASDAQ stock exchange in 1983. [5]

In 1988, Walter sold Cardinal Health's food operations to Roundy's. [5] [6] From 1991 to 1996, the company's sales grew from $1.2 billion to $8.9 billion. [7] The company changed its name to Cardinal Health in 1994, and became the third-largest pharmaceutical wholesaler in the United States. [6] [8]

2000–2019

R. Kerry Clark, a former executive and vice chairman at Procter & Gamble, was appointed president and CEO in April 2006, with Robert D. Walter retaining Chairmanship of the board. [9] In September 2008, the company announced Clark and Walter would retire and George S. Barrett would become the chairman and CEO. [10] [11]

In 2009, Cardinal Health completed the spin-off of its clinical and medical products businesses into an independent medical technology company called CareFusion with David Schlotterbeck as CEO. [12] [13] Cardinal Health is now traded on the NYSE under symbol CAH. [14]

In December 2013, it was announced that Cardinal Health would partner with CVS Caremark to form a generic drug sourcing operation in the United States. [15] The venture was named Red Oak Sourcing and began operations in July 2014. [16]

Between 2014 and 2016, Cardinal, alongside McKesson Corporation, and AmerisourceBergen, spent $13 million lobbying Congress to pass Congressman Tom Marino's "Ensuring Patient Access and Effective Drug Enforcement Act". [17] The bill, which increases the burden of proof enforcers need to show against drug distributors, was signed into law by President Barack Obama in April 2016. [18]

In January 2018, Michael Kaufmann assumed the role of CEO after serving as CFO of the company. [19]

Opioid lawsuits

In 2019, Cardinal was one of several drug distributors named in lawsuits related to the opioid crisis in the US. [20] In July 2021, Cardinal Health and other pharmaceutical companies agreed to participate in a $26 billion settlement. [21] Cardinal will pay $6.4 billion over 18 years. [21]

In May 2020, Oklahoma Attorney General Mike Hunter sued Cardinal Health in Bryan County District Court, Oklahoma. The lawsuit alleged that he company's actions helped fuel Oklahoma's opioid crisis. The suit was filed along with lawsuits against AmerisourceBergen and McKesson, and the three lawsuits allege that the three companies provided "enough opioids to Bryan County that every adult resident there could have had 144 hydrocodone tablets." [22]

2020–present

As of August 2021, it is ranked 14 on the Fortune 500 list with FY2020 annual revenue of $152.9 billion. [23] The firm employs 48,000 people worldwide. [23]

Acquisitions

In 1995, Medicine Shoppe International, the country's largest franchiser of retail pharmacies, was acquired. [5] The merger represented the first non-distribution acquisition by Cardinal Health. [5]

In 1996, Cardinal Health acquired Pyxis Corporation, a company that developed automated pill dispensers for hospitals, for $867 million. [24]

In 1997, Cardinal Health planned to purchase Bergen Brunswig Corp., to which McKesson Corporation responded with a bid to purchase Amerisource. [25] Instead, Amerisource and Bergen merged into AmerisourceBergen. [25] Later that year, Cardinal Health completed the acquisition of Owen Healthcare, the second-largest provider of pharmacy management services in the U.S. at the time. [26]

In 1999, the firm acquired the Chicago-based medical products manufacturer and distributor, Allegiance Healthcare (formerly a division of Baxter Healthcare). [5] In 2001, the company acquired Bindley Western Industries, a wholesale distributor of pharmaceuticals based in Indianapolis. [27]

In April 2006, Cardinal Health purchased Niagara Falls-based ParMed Pharmaceuticals for $40.1 million. [28] In June 2007, the firm announced the completion of a tender offer for VIASYS Healthcare. [29]

In June 2010, Cardinal Health announced plans to purchase Healthcare Solutions Holding, a specialty pharmaceutical services company, for $517 million. [30] In December 2010, the company acquired Kinray, an independent pharmaceutical wholesaler, increasing Cardinal Health's presence in the independent pharmacy market by 40 percent. [31] From 2010 to 2014, Cardinal Health acquired 18 companies including Yong Yu, a Chinese drug distributor. [32] Cardinal sold Yong Yu in 2017 to Shanghai Pharmaceuticals Holding Co. Ltd. for $1.2 billion. [33]

In July 2014, Cardinal Health and CVS formed Red Oak Sourcing, the largest generic drug sourcing operation in the United States. [3] [34] The companies started buying generic drugs around the world to sell in U.S. markets. [3]

In March 2015, Cardinal Health signed an agreement to acquire Johnson & Johnson's Cordis (medical) division, a cardiology and endovascular device manufacturer, for $1.94 billion. [35] [36] The acquisition was completed on October 4, 2015. [37] Cardinal sold the division in August 2021 to Hellman & Friedman, a private equity firm, for $1 billion. [38]

In April 2017, Cardinal Health announced the plan to acquire the patient product portfolio from Medtronic for $6.1 billion. [39] [40] The acquisition was completed on July 30, 2017. [40]

Controversy

Role in the Opioid epidemic

Multiple legal settlements have demonstrated Cardinale Health's role in the US Opioid epidemic, though the company never admitted wrongdoing:

Restatements

In September 2004, Cardinal Health announced plans to restate past results for fiscal 2001, 2002, 2003, and the first three quarters of 2004 downward, after an accounting review and an ongoing federal investigation. [46] In 2005, in connection with the Audit Committee's conclusions reached in September and October 2004, the company made certain reclassification and restatement adjustments to its fiscal 2004 and prior historical consolidated financial statements. [47] According to The Wall Street Journal , "Analysts called the restatement decision troubling, yet limited in scope." [46]

FDA action

In August 2006, Cardinal Health ceased production of its Alaris SE infusion pump after approximately 1300 units were seized[ why? ] by the United States Food and Drug Administration (FDA). [48] In February 2007, Cardinal Health signed a consent decree with the FDA which promised procedures to guarantee the safety of the Alaris SE. [12] After FDA inspections, Cardinal Health entered into a further consent agreement with the FDA in 2009. [12]

DEA investigation into Oxycodone diversion

In 2008, Cardinal Health agreed to pay $34 million in civil penalties to settle DEA allegations that it failed to report suspicious orders of hydrocodone. The fine followed a 10-month DEA suspension of a Lakeland, Florida distribution facility and two others in New Jersey and Washington. [49] On February 2, 2012, the Drug Enforcement Administration again suspended the license of the firm's Lakeland distribution center to distribute controlled substances on charges that it had allowed four Florida pharmacies to purchase excessive amounts of controlled substances, in particular oxycodone. [50]

Cardinal Health obtained a restraining order against the suspension, but the suspension was upheld on February 29 by a Federal district court because the court agreed with the DEA that Cardinal Health's activities represented an "imminent danger to the public." [51] The company stated that it blocked two of the pharmacies, (Brooks Pharmacy in Bonita Springs, Florida, and Gulf Coast Medical in Panama City, Florida), and notified the corporate owners of the two pharmacies that were part of national chains, two CVS stores in Sanford, Florida. [50]

In February 2012, Joseph Rannazzisi, chief of the Drug Enforcement Administration’s Office of Diversion Control, issued immediate suspension orders against Cardinal's supply of oxycodone to suspected pill mills. [17] These orders were filed after Deputy Attorney General James M. Cole met with Rannazzisi to ask if he had met with Cardinal about the investigation. [17] Cole stated that he believed “it made good sense to listen to what Cardinal had to say” regarding the investigation. [17] That year, Cardinal and the DEA reached a settlement that suspended Cardinal's facility in Lakeland, Florida from selling pain killers or other drugs for two years. [52] In 2016, Cardinal was fined $44 million for after the investigation concluded. [53]

In January 2022, Cardinal Health, Johnson & Johnson, McKesson, and AmerisourceBergen agreed to pay $26 billion to settle with all but five of the states suing them. [54] Had the states gone to court, the companies could have faced up to $95 billion in penalties. [55]

Finances

Annual financial statistics are displayed below:

YearRevenue
in mil. USD$		Net income
in mil. USD$		Total Assets
in mil. USD$		Price per Share
in USD$		Employees
200572,6664,46021,83833.48
200679,6644,81423,43338.32
200786,7555,19723,15438.62
200887,4083,77723,44828.75
200995,9923,74825,11921.10
201098,5033,78119,99028.37
2011102,6444,16222,84635.90
2012107,5524,54124,26035.61
2013101,0934,92125,81945.2033,600
201491,0845,16126,03365.9234,000
2015102,5315,71230,14279.3934,500
2016121,5466,54334,12274.1437,300
2017129,9766,54440,11269.2240,400
2018136,8097,18139,95157.4750,200
2019145,5341,36340,96348.3731,000
2020152,922-3,69640,76651.6730,000
2021162,46761144,45356.6647,300
2022181,326-93843,87859.2146,500
2023204,97933043,34985.1148,000

Cardinal Health Foundation

The Cardinal Health Foundation is the charitable arm of Cardinal Health. The company makes annual product donations of over $9 million through international relief organizations and provides up to $1,000 in matching funds for every Cardinal Health employee that makes a charitable donation. [56] In 2008, the foundation established its E3 Grant Program. [57] Over the past seven years, the Foundation has invested more than $7.15 million in funding to 241 hospitals, health systems or other health-related organizations. [58]

Cardinal Health also supports organizations such as Ronald McDonald House Charities, and was named Benefactor of the Year at the 2011 Corporate Caring Awards. [56] In 2015, the foundation contributed $3 million to the Solutions for Patient Safety project, which has raised over $11 million nationally for efforts to improve safety initiatives in children's hospitals. [59]

Related Research Articles

<span class="mw-page-title-main">CVS Pharmacy</span> American pharmacy chain

CVS Pharmacy, Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts in 1963.

Walgreen Company is an American company that operates the second-largest pharmacy store chain in the United States, behind CVS Health. It specializes in filling prescriptions, health and wellness products, health information, and photo services. It was founded in Chicago in 1901, and is headquartered in the Chicago suburb of Deerfield, Illinois. On December 31, 2014, Walgreens and Switzerland-based Alliance Boots merged to form a new holding company, Walgreens Boots Alliance. Walgreens became a subsidiary of the new company, which retained its Deerfield headquarters and trades on the Nasdaq under the symbol WBA.

<span class="mw-page-title-main">Alliance Healthcare</span> European health products distributor

Alliance Healthcare, formerly Alliance UniChem, is a wholesaler, distributor and retailer of pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres, and hospitals from over 288 distribution centres in 11 countries.

McKesson Corporation is a publicly-traded American company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 51,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a member of the S&P 500 and New York Stock Exchange, where it is traded under the ticker symbol NYSE: MCK.

Drug diversion is a medical and legal concept involving the transfer of any legally prescribed controlled substance from the individual for whom it was prescribed to another person for any illicit use. The definition varies slightly among different jurisdictions, but the transfer of a controlled substance alone usually does not constitute a diversion, since certain controlled substances that are prescribed to a child are intended to be administered by an adult, as directed by a medical professional. The term comes from the "diverting" of the drugs from their original licit medical purpose. In some jurisdictions, drug diversion programs are available to first time offenders of diversion drug laws, which "divert" offenders from the criminal justice system to a program of education and rehabilitation.

Robert D. Walter is an American businessman best known for his role in the creation of Cardinal Health.

Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It is considered one of the largest pharmaceutical companies in the world and distributs generic pharmaceuticals, over-the-counter healthcare products as well as home healthcare supplies and equipment.

Longs Drugs is an American chain owned by parent company CVS Health with approximately 70 drugstores throughout the state of Hawaii and formerly in the Continental US.

Express Scripts Holding Company is a pharmacy benefit management (PBM) organization. In 2017 it was the 22nd-largest company in the United States by total revenue as well as the largest pharmacy benefit management (PBM) organization in the United States. Express Scripts had 2016 revenues of $100.752 billion. Since December 20, 2018, the company has been a direct subsidiary of Bloomfield, Connecticut-based Cigna.

LloydsPharmacy was the trading name of Lloyds Pharmacy Ltd, a British pharmacy company, which was formed by a merger in 1998 and by 2021 was the second-largest community pharmacy company in the UK. The company, which was owned by McKesson Corporation from 2014 and Aurelius Group from 2022, ceased trading in November 2023 and later entered voluntary liquidation. Some stores were closed and the remaining 1,054 were sold to new owners.

PharMerica is a Fortune 1000 company formed in January 2007 from the merger of Kindred Healthcare's pharmacy business with a subsidiary of AmerisourceBergen.

CVS Health Corporation is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands. The company is the world's second largest healthcare company, behind UnitedHealth Group. In 2023, the company was ranked 64th in the Forbes Global 2000.

<span class="mw-page-title-main">Mallinckrodt</span> Irish domiciled pharmaceutical

Mallinckrodt Pharmaceuticals plc is an American-Irish domiciled manufacturer of specialty pharmaceuticals, generic drugs and imaging agents. In 2017, it generated 90% of its sales from the U.S. healthcare system. While Mallinckrodt is headquartered in Ireland for tax purposes, its operational headquarters are in the U.S. Mallinckrodt's 2013 tax inversion to Ireland drew controversy when it was shown Acthar was Medicaid's most expensive drug.

<span class="mw-page-title-main">W. Mark Lanier</span> American lawyer (born 1960)

William Mark Lanier is an American trial lawyer and founder and CEO of the Lanier Law Firm. He has led a number of high-profile product litigation suits resulting in billions of dollars in damages, including Johnson & Johnson baby powder and Merck & Co.'s Vioxx drug.

John H. Hammergren is an American businessman. He is best known for his role as chairman and CEO of McKesson Corporation since 1999. On November 1, 2018, Hammergren announced his plan to retire. On April 1, 2019, he officially retired from McKesson. He was succeeded by Brian Tyler.

Change Healthcare Inc. is a provider of revenue and payment cycle management that connects payers, providers, and patients within the U.S. healthcare system. The name also refers to a company founded in 2007 which subsequently became part of the current conglomerate. The company operates the largest financial and administrative information exchange in the United States.

Walgreens Boots Alliance, Inc. (WBA) is an American multinational holding company headquartered in Deerfield, Illinois, which owns the retail pharmacy chains Walgreens in the US and Boots in the UK, as well as several pharmaceutical manufacturing and distribution companies. The company was formed on December 31, 2014, after Walgreens bought the 55% stake in Alliance Boots that it did not already own. The total price of the acquisition was $4.9 billion in cash and 144.3 million common shares with fair value of $10.7 billion. Walgreens had previously purchased 45% of the company for $4.0 billion and 83.4 million common shares in August 2012 with an option to purchase the remaining shares within three years. Walgreens became a subsidiary of the newly created company after the transactions were completed. As of 2022, Walgreens Boots Alliance is ranked #18 on the Fortune 500 rankings of the largest United States corporations by total revenue.

<span class="mw-page-title-main">Larry Merlo</span>

Larry J. Merlo is the former president and CEO of CVS Health.

Specialty pharmacy refers to distribution channels designed to handle specialty drugs — pharmaceutical therapies that are either high cost, high complexity and/or high touch. High touch refers to higher degree of complexity in terms of distribution, administration, or patient management which drives up the cost of the drugs. In the early years specialty pharmacy providers attached "high-touch services to their overall price tags" arguing that patients who receive specialty pharmaceuticals "need high levels of ancillary and follow-up care to ensure that the drug spend is not wasted on them." An example of a specialty drug that would only be available through specialty pharmacy is interferon beta-1a (Avonex), a treatment for MS that requires a refrigerated chain of distribution and costs $17,000 a year. Some specialty pharmacies deal in pharmaceuticals that treat complex or rare chronic conditions such as cancer, rheumatoid arthritis, hemophilia, H.I.V. psoriasis, inflammatory bowel disease (IBD) or Hepatitis C. "Specialty pharmacies are seen as a reliable distribution channel for expensive drugs, offering patients convenience and lower costs while maximizing insurance reimbursements from those companies that cover the drug. Patients typically pay the same co-payments whether or not their insurers cover the drug." As the market demanded specialization in drug distribution and clinical management of complex therapies, specialized pharma (SP) evolved.„ Specialty pharmacies may handle therapies that are biologics, and are injectable or infused. By 2008 the pharmacy benefit management dominated the specialty pharmacies market having acquired smaller specialty pharmacies. PBMs administer specialty pharmacies in their network and can "negotiate better prices and frequently offer a complete menu of specialty pharmaceuticals and related services to serve as an attractive 'one-stop shop' for health plans and employers."

<i>The Crime of the Century</i> (2021 film) American documentary film

The Crime of the Century is an American two-part documentary film directed, produced, and written by Alex Gibney. The film follows the opioid epidemic in the United States, and the political operatives, government regulations and corporations that enable the abuse of opioids, particularly the Sackler family and Purdue Pharma.

References

  1. ↑ "FY 2024 Annual Report (Form 10-K)". U.S. Securities and Exchange Commission. August 14, 2024. Retrieved August 14, 2024.
  2. ↑ "Cardinal Health accused of fraudulent radiopharmaceutical contracting scheme". Modern Healthcare. 2020-05-12. Retrieved 2021-08-16.
  3. 1 2 3 Wartenberg, Steve (November 6, 2014). "Turnaround succeeding, Cardinal Health says". The Columbus Dispatch. Retrieved June 10, 2015.
  4. ↑ Williams, Mark. "Cardinal Health CEO Quietly Builds Powerful Company". The Ledger. Retrieved 2021-08-16.[ permanent dead link ]
  5. 1 2 3 4 5 6 "THE CARDINAL RULES: GROWTH, AGILITY: CARDINAL CEO ROBERT WALTER HAS USED RELENTLESS DEALMAKING TO BUILD A DIVERSE HEALTHCARE GIANT". Modern Healthcare. 2006-10-03. Retrieved 2021-08-16.
  6. 1 2 "Executive Interview: Bob Walter". Journal of Healthcare Contracting. March 2005. Retrieved June 10, 2015.
  7. ↑ "The $9 Billion Company Nobody Knows". Bloomberg Business. March 2, 1997. Retrieved June 10, 2015.
  8. ↑ Wankel, Charles (2009). Encyclopedia of Business in Today's World: A - C. Vol. 1. SAGE Publications. ISBN   9781412964272 . Retrieved June 10, 2015.
  9. ↑ "Walter steps down at Cardinal Health, P&G exec takes over". Columbus Business First. April 17, 2006. Retrieved June 10, 2015.
  10. ↑ Ghose, Carrie (October 6, 2008). "Next Cardinal Health CEO sees bright future after spinoff". Columbus Business First. Retrieved June 10, 2015.
  11. ↑ Wartenberg, Steve (May 19, 2013). "Cardinal Health's CEO uses background to think outside the box". The Columbus Dispatch. Retrieved June 10, 2015.
  12. 1 2 3 "Cardinal Health to name spinoff after CareFusion line". Healthcare IT News. February 18, 2009. Retrieved June 13, 2018.
  13. ↑ Rhea, Shawn (September 2, 2009). "Cardinal Health completes CareFusion spinoff". Modern Healthcare. Retrieved June 10, 2015.
  14. ↑ "Cardinal Health Inc(NYSE:CAH)".
  15. ↑ Berkrot, Bill (10 December 2013). "CVS, Cardinal Health form U.S. generic drug venture". Reuters . Archived from the original on 10 December 2013. Retrieved 11 December 2013.
  16. ↑ Ghose, Carrie (May 1, 2014). "Cardinal Health, CVS generics venture Red Oak on track for July start". Columbus Business First . Retrieved June 13, 2018.
  17. 1 2 3 4 Lenny Bernstein; Scott Higham (22 October 2016). "Investigation: The DEA slowed enforcement while the opioid epidemic grew out of control". The Washington Post . Retrieved 17 March 2017.
  18. ↑ S. 483, 114th Cong. (2015).
  19. ↑ Rose, Marla Matzer. "Cardinal Health's CEO Mike Kaufmann is a steady hand in his new role". The Columbus Dispatch. Archived from the original on 2021-08-16. Retrieved 2021-08-16.
  20. ↑ Hakim, Danny; Rashbaum, William K.; Rabin, Roni Caryn (2019-04-22). "The Giants at the Heart of the Opioid Crisis". The New York Times. ISSN   0362-4331 . Retrieved 2021-08-20.
  21. 1 2 3 Williams, Mark. "Cardinal Health to take $140 million charge tied to opioid settlement". The Columbus Dispatch. Retrieved 2021-08-20.
  22. ↑ Carey, Liz (2020-05-05). "Oklahoma Attorney General refiles opioid lawsuit against three distributors". Health Crisis Alert. Retrieved 2020-05-05.
  23. 1 2 "Cardinal Health | 2021 Fortune 500". Fortune. Retrieved 2021-08-16.
  24. ↑ Freudenheim, Milt (February 8, 1996). "Cardinal Deal To Buy Pyxis In Stock Swap". The New York Times. Retrieved June 10, 2015.
  25. 1 2 "McKesson Plans to Buy Rival AmeriSource". Los Angeles Times . Archived from the original on 7 November 2012.
  26. ↑ "Cardinal Health to Purchase Owen Healthcare". The New York Times. November 28, 1996. Retrieved June 10, 2015.
  27. ↑ "Cardinal Health completes Bindley Western acquisition". www.bizjournals.com. 15 February 2001. Archived from the original on 2004-04-17. Retrieved 2021-08-16.
  28. ↑ Staff. "Cardinal Health buying ParMed for $40.1 million". The Buffalo News. Retrieved 2021-08-20.
  29. ↑ "Cardinal Health acquires VIASYS for $1.5B". Healthcare IT News. May 14, 2007. Retrieved June 10, 2015.
  30. ↑ Taulli, Tom (June 9, 2010). "Cardinal Health Pays $517 Million for Obscure Specialty Pharma Firm". Daily Finance. Retrieved June 10, 2015.
  31. ↑ Dinah Wisenberg Brin, "Cardinal Health to Purchase Kinray", The Wall Street Journal, November 19, 2010
  32. ↑ Glenn, Brandon (2010-11-29). "Cardinal Health buys Chinese drug distributor for $470 million". MedCity News. Retrieved 2021-08-20.
  33. ↑ "Cardinal Health sells China business for $1.2B". www.bizjournals.com. Archived from the original on 2022-01-16. Retrieved 2021-08-20.
  34. ↑ "Cardinal, CVS to form venture for generics". The Columbus Dispatch. Archived from the original on 2021-08-20. Retrieved 2021-08-20.
  35. ↑ Wartenberg, Steve (March 3, 2015). "Cardinal Health to acquire Cordis for $1.9 billion". The Columbus Dispatch. Retrieved June 10, 2015.
  36. ↑ "Cardinal Health to Buy J&J's Heart Business for $1.94B". Fox Business. March 2, 2015. Archived from the original on June 11, 2015. Retrieved June 10, 2015.
  37. ↑ Health, Cardinal. "Cardinal Health Completes Acquisition Of Cordis". www.prnewswire.com. Retrieved 14 April 2018.
  38. ↑ "Cardinal Health to sell off its Cordis device division in $1B deal". FierceBiotech. 15 March 2021. Retrieved 2021-08-20.
  39. ↑ "Cardinal Health to acquire Medtronic medical supplies business for $6.1B". Modern Healthcare. 2017-04-18. Retrieved 2021-08-20.
  40. 1 2 "Medtronic closes on $6.1 billion sale of supply lines to Cardinal Health". Star Tribune. Retrieved 2021-08-20.
  41. ↑ "District of Maryland | Cardinal Health Agrees to $44 Million Settlement for Alleged Violations of Controlled Substances Act | United States Department of Justice". www.justice.gov. 2016-12-23. Retrieved 2024-11-04.
  42. ↑ Mann, Brian (February 25, 2022). "4 U.S. companies will pay $26 billion to settle claims they fueled the opioid crisis". NPR. Retrieved November 4, 2024.
  43. ↑ LaCroix, Kevin (2022-05-30). "Cardinal Health Opioid-Related Derivative Suit Settled for $124 Million". The D&O Diary. Retrieved 2024-11-04.
  44. ↑ Raymond, Nate (August 30, 2024). "Drug distributors strike $300 mln opioid settlement with US health plans". Reuters. Retrieved November 4, 2024.
  45. ↑ "City of Baltimore Reaches $152.5 Million Deal with Cardinal Health to Resolve Ongoing Opioid Litigation". Mayor Brandon M. Scott. 2024-08-16. Retrieved 2024-11-04.
  46. 1 2 Burton, Thomas M. (September 14, 2004). "Cardinal Health to Restate Net, Citing Bulk-Revenue Accounting". The Wall Street Journal. Retrieved May 17, 2016.
  47. ↑ "CARDINAL HEALTH INC - 10-Q Quarterly Report".
  48. ↑ "Cardinal Health Suspends Production of Alaris SE Infusion Pump Following FDA Actions". Cardinal Health. August 28, 2006. Archived from the original on April 18, 2021. Retrieved June 13, 2018.
  49. ↑ Schoenberg, Tom (2012-02-29). "Cardinal Health Blocked From Shipping Painkiller in Florida". Bloomberg. Retrieved 2012-09-01.
  50. 1 2 Donna Leinwand Leger "DEA aims big in Cardinal Health painkiller case" USA Today Feb 27, 2012
  51. ↑ Donna Leinwand Leger "Judge blocks Cardinal Health drug shipments in Fla." USA Today Deb 29, 2012
  52. ↑ Raymond, Nate (2016-12-23). "Cardinal settles with U.S. over painkiller shipments to pharmacies". Reuters. Retrieved 2021-08-20.
  53. ↑ "Cardinal Health Announces Civil Settlement with DOJ". ir.cardinalhealth.com. Retrieved 14 April 2018.
  54. ↑ Raymond, Nate (2022-01-27). "Most U.S. local governments opt to join $26 bln opioid settlement". Reuters. Retrieved 2022-02-21.
  55. ↑ Raymond, Nate (2021-11-16). "Washington state, in $95 billion opioid trial, blames drug distributors for crisis". Reuters. Retrieved 2022-02-21.
  56. 1 2 Dutton, Melissa Kossler (April 13, 2011). "Benefactor of the Year: Cardinal Health Inc". Columbus Business First. Retrieved June 10, 2015.
  57. ↑ "Cardinal Health Foundation invites healthcare providers to apply for grants to improve patient safety, efficiency". Healthcare Finance. October 13, 2011. Retrieved June 10, 2015.
  58. ↑ "Financial Statements for Cardinal Health, Inc. - Google Finance" . Retrieved October 25, 2016.
  59. ↑ Sutherly, Ben (February 11, 2015). "Hospital safety initiative helps Ohio kids". The Columbus Dispatch. Retrieved June 10, 2015.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.